Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial

2010 Hser, 1993, A 24-year follow-up of California narcotics addicts, Arch Gen Psychiatry, 50, 577, 10.1001/archpsyc.1993.01820190079008 Wilcox, 2004, Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies, Drug Alcohol Depend, 76S, S11, 10.1016/j.drugalcdep.2004.08.003 Cook, 2010 Mathers, 2010, HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, Lancet, 375, 1014, 10.1016/S0140-6736(10)60232-2 Ball, 1991 Mattick, 2008, Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD002207.pub3 Marsch, 1988, The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis, Addiction, 93, 515, 10.1046/j.1360-0443.1998.9345157.x Kleber, 2007, Pharmacologic treatments for opioid dependence: detoxification and maintenance options, Dialogues Clin Neurosci, 9, 455, 10.31887/DCNS.2007.9.2/hkleber McLellan, 2003, Components of successful addiction treatment, 429 Nunes, 2006, Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?, Am J Drug Alcohol Depend, 32, 503, 10.1080/00952990600918973 Minozzi, 2006, Oral naltrexone maintenance treatment for opioid dependence, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD001333.pub2 Hulse, 2009, Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone, Arch Gen Psychiatry, 66, 1108, 10.1001/archgenpsychiatry.2009.130 Kunøe, 2009, Naltrexone implants after in-patient treatment for opioid dependence: randomized controlled trial, Br J Psychiatry, 194, 541, 10.1192/bjp.bp.108.055319 Comer, 2006, Injectable, sustained-release naltrexone for the treatment of opioid dependence, Arch Gen Psychiatry, 63, 210, 10.1001/archpsyc.63.2.210 Garbutt, 2005, Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial, JAMA, 293, 1617, 10.1001/jama.293.13.1617 O'Malley, 2007, Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment, J Clin Psychopharmacol, 27, 507, 10.1097/jcp.0b013e31814ce50d Gastfriend, 2011, Intramuscular extended-release naltrexone: current evidence, Ann NY Acad Sci, 1216, 144, 10.1111/j.1749-6632.2010.05900.x 2000 Mercer, 1999 Sobell, 1992, Timeline follow-back: a technique for assessing self-reported alcohol consumption, 41 Krupitsky, 2004, Naltrexone for heroin dependence treatment in St. Petersburg, Russia, J Subst Abuse Treat, 26, 285, 10.1016/j.jsat.2004.02.002 Metzger, 2001, Assessment of substance abuse: HIV risk assessment battery (RAB) Ware, 2000 1990, Euroqol—a new facility for the measurement of health-related quality of life, Health Policy, 16, 199, 10.1016/0168-8510(90)90421-9 1976 van der Waerden, 1953, Order tests for the two-sample problem. II, III, Proc K Ned Akad Wet A, 564, 303 Holm, 1979, A simple sequentially rejective multiple test procedure, Scand J Statist, 6, 65 Amirdjanova, 2008, Population indices of quality of life on SF-36: results of the multicentral study of quality of life “MIRAZH”, Rheumatol Sci Pract, 1, 36, 10.14412/1995-4484-2008-852 Dijkstra, 2007, Does naltrexone affect craving in abstinent opioid-dependent patients?, Addict Biol, 12, 176, 10.1111/j.1369-1600.2007.00067.x Dunbar, 2006, Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone, Alcohol Clin Exp Res, 30, 480, 10.1111/j.1530-0277.2006.00052.x Dean, 2008, Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone, Pharmacol Biochem Behav, 89, 515, 10.1016/j.pbb.2008.02.006 Lobmaier, 2010, The pharmacological treatment of opioid addiction—a clinical perspective, Eur J Clin Pharmacol, 66, 537, 10.1007/s00228-010-0793-6